Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • NF-κB
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

lymphocyte depletion

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
Alemtuzumab
T9919216503-57-0
Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.
  • $297
In Stock
Size
QTY
Gatralimab
GZ-402668
T783191826020-80-7
Gatralimab (GZ-402668) is a next-generation humanized anti-CD52 monoclonal antibody for which phase 1 clinical trial data indicate it successfully achieves the intended pharmacodynamic effect of lymphocyte depletion followed by subsequent repopulation, all with an acceptable safety profile, supporting its further investigation about relapsing-remitting multiple sclerosis (MS).
  • $247
In Stock
Size
QTY